Inflammatory Dietary Scores and Their Association with Clinical Outcomes in Coronary Heart Disease

Why It Matters

Recognizing dietary inflammation as an independent risk factor broadens secondary‑prevention options for heart disease and supports adding nutrition metrics like the DII to cardiovascular risk models.

Key Takeaways

• High DII quartile patients had 1.82× MACE risk versus lowest
• One‑unit DII increase raised MACE risk by 21%
• All‑cause mortality rose from 8% to 18.4% across DII quartiles
• Cardiac readmission odds nearly doubled in highest DII group
• DII positively correlated with hs‑CRP, IL‑6, and TNF‑α levels

Pulse Analysis

The Dietary Inflammatory Index (DII) quantifies how food choices influence systemic inflammation, a key driver of atherosclerotic plaque instability. While prior population studies linked high DII scores to incident coronary disease, this new analysis extends the evidence to patients with established CHD, demonstrating that diet‑related inflammation continues to shape prognosis even after angiographic confirmation. By leveraging a validated food frequency questionnaire and adjusting for traditional risk factors, the study isolates the incremental hazard attributable to pro‑inflammatory eating patterns.

The findings have immediate implications for risk stratification. Patients in the top DII quartile faced an 82% higher hazard of major adverse cardiovascular events and a 68% increase in all‑cause mortality compared with those consuming anti‑inflammatory diets. Moreover, the dose‑response relationship—21% higher MACE risk per DII unit—mirrors the magnitude observed for classic risk markers such as LDL‑cholesterol. These data suggest that incorporating DII into existing prediction tools could refine therapeutic targeting, prompting clinicians to prioritize dietary counseling alongside pharmacologic therapy in secondary prevention programs.

Looking ahead, the study underscores the need for interventional trials that test whether lowering DII through Mediterranean‑style or plant‑forward diets can translate into fewer events. Prospective, multicenter cohorts should capture longitudinal dietary changes and broader inflammatory panels to confirm causality. If successful, DII‑guided nutrition could become a standard component of personalized cardiology, complementing statins, antiplatelet agents, and lifestyle modifications to curb the residual risk that persists in contemporary CHD management.